180 related articles for article (PubMed ID: 20462970)
1. Expression of adrenomedullin 2/intermedin, a possible reno-protective peptide, is decreased in the kidneys of rats with hypertension or renal failure.
Hirose T; Totsune K; Mori N; Mori T; Morimoto R; Metoki H; Asayama K; Kikuya M; Ohkubo T; Kohzuki M; Takahashi K; Imai Y
Am J Physiol Renal Physiol; 2010 Jul; 299(1):F128-34. PubMed ID: 20462970
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of intermedin and its receptor in the myocardium and aorta in spontaneously hypertensive rats.
Zeng Q; Yuan Y; Wang X; Wu HM; Fan L; Qi YF; Tang CS; Cai Y; Pan CS
Peptides; 2009 Feb; 30(2):391-9. PubMed ID: 19041918
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure.
Hirose T; Totsune K; Mori N; Morimoto R; Hashimoto M; Nakashige Y; Metoki H; Asayama K; Kikuya M; Ohkubo T; Hashimoto J; Sasano H; Kohzuki M; Takahashi K; Imai Y
Eur J Heart Fail; 2008 Sep; 10(9):840-9. PubMed ID: 18692436
[TBL] [Abstract][Full Text] [Related]
4. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
Pan ChS; Jiang W; Wu ShY; Zhao J; Pang YZ; Tang ChS; Qi YF
Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
[TBL] [Abstract][Full Text] [Related]
5. Adrenomedullin and its receptor complexes in remnant kidneys of rats with renal mass ablation: decreased expression of calcitonin receptor-like receptor and receptor-activity modifying protein-3.
Totsune K; Takahashi K; Mackenzie HS; Arihara Z; Satoh F; Sone M; Murakami O; Ito S; Brenner BM; Mouri T
Peptides; 2001 Nov; 22(11):1933-7. PubMed ID: 11754984
[TBL] [Abstract][Full Text] [Related]
6. [Alterations of intermedin and its receptor system in oleic acid-induced acute lung injury of rats].
Yu XM; Liu XM; Qi YF; Zhang J; Tang CS
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):496-500. PubMed ID: 17068622
[TBL] [Abstract][Full Text] [Related]
7. Role of increased circulating and renal adrenomedullin in rats with malignant hypertension.
Nishikimi T; Yoshihara F; Kanazawa A; Okano I; Horio T; Nagaya N; Yutani C; Matsuo H; Matsuoka H; Kangawa K
Am J Physiol Regul Integr Comp Physiol; 2001 Dec; 281(6):R2079-87. PubMed ID: 11705795
[TBL] [Abstract][Full Text] [Related]
8. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic.
Wang X; Nishikimi T; Akimoto K; Tadokoro K; Mori Y; Minamino N
J Hypertens; 2003 Jun; 21(6):1171-81. PubMed ID: 12777955
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical localization of adrenomedullin 2/intermedin-like immunoreactivity in human hypothalamus, heart and kidney.
Takahashi K; Kikuchi K; Maruyama Y; Urabe T; Nakajima K; Sasano H; Imai Y; Murakami O; Totsune K
Peptides; 2006 Jun; 27(6):1383-9. PubMed ID: 16359754
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
Zhao Y; Bell D; Smith LR; Zhao L; Devine AB; McHenry EM; Nicholls DP; McDermott BJ
J Pharmacol Exp Ther; 2006 Mar; 316(3):1269-81. PubMed ID: 16326922
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis.
Takahashi K; Morimoto R; Hirose T; Satoh F; Totsune K
J Mol Neurosci; 2011 Feb; 43(2):182-92. PubMed ID: 20596793
[TBL] [Abstract][Full Text] [Related]
14. Intermedin in paraventricular nucleus attenuates sympathetic activity and blood pressure via nitric oxide in hypertensive rats.
Zhou YB; Sun HJ; Chen D; Liu TY; Han Y; Wang JJ; Tang CS; Kang YM; Zhu GQ
Hypertension; 2014 Feb; 63(2):330-7. PubMed ID: 24218431
[TBL] [Abstract][Full Text] [Related]
15. Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension.
Tadokoro K; Nishikimi T; Mori Y; Wang X; Akimoto K; Matsuoka H
Regul Pept; 2003 Apr; 112(1-3):71-8. PubMed ID: 12667627
[TBL] [Abstract][Full Text] [Related]
16. Expression of adrenomedullin 2/intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues.
Morimoto R; Satoh F; Murakami O; Hirose T; Totsune K; Imai Y; Arai Y; Suzuki T; Sasano H; Ito S; Takahashi K
J Endocrinol; 2008 Jul; 198(1):175-83. PubMed ID: 18460550
[TBL] [Abstract][Full Text] [Related]
17. Alteration of renal adrenomedullin and its receptor system in the severely hypertensive rat: effect of diuretic.
Nishikimi T; Wang X; Akimoto K; Tadokoro K; Mori Y; Ishikawa Y; Ishimura K; Yoshihara F; Minamino N; Kangawa K; Matsuoka H
Regul Pept; 2005 Jan; 124(1-3):89-98. PubMed ID: 15544845
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure.
Mori N; Hirose T; Nakayama T; Ito O; Kanazawa M; Imai Y; Kohzuki M; Takahashi K; Totsune K
Peptides; 2009 Feb; 30(2):400-8. PubMed ID: 18955095
[TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of intermedin/adrenomedullin-2 in a cellular model of human pulmonary arterial hypertension.
Holmes D; Corr M; Thomas G; Harbinson M; Campbell M; Spiers P; Bell D
Peptides; 2020 Apr; 126():170267. PubMed ID: 32017948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
